Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- RADIANT-TBIndependent statistical analysis of Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03851588).
- Radiation Dose Escalation in Esophageal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Radiation Dose Escalation in Esophageal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03082586).
- Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Radiation Therapy After Surgery in Treating Women With Phyllodes Tumor of the Breast: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy After Surgery in Treating Women With Phyllodes Tumor of the Breast: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver Metastases: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver Metastases: primary…
- Radiation Therapy to Treat Musculoskeletal Tumors: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy to Treat Musculoskeletal Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00186992).
- Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery: primary endpoint results, effect estimate with confidence interval,…
- RADIAUSIndependent statistical analysis of Risperidone and Desipramine in Alcohol Use and Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01411085).
- RADICALIndependent statistical analysis of Repeated Amiodarone Dosing In Cardiac surgicaL Procedures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05004077).
- RadioCityIndependent statistical analysis of A Study of the Performance of Certain Prevail Implants Used in Short Fixed Cases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Radiofrequency Ablation vs Laser Ablation of the Incompetent Greater Saphenous Vein: Complete Statistical AnalysisIndependent statistical analysis of Radiofrequency Ablation vs Laser Ablation of the Incompetent Greater Saphenous Vein: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Radiofrequency Hyperthermia Safety Study: Complete Statistical AnalysisIndependent statistical analysis of Radiofrequency Hyperthermia Safety Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05399771).
- Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- RADIUSIndependent statistical analysis of Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- RAFAELOCALIndependent statistical analysis of Evaluation of the Value of Perianal Infiltration During Thermodestruction of Haemorrhoidal Disease by Radiofrequency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RAFFAELLOIndependent statistical analysis of Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01534962).
- RAINBOWIndependent statistical analysis of RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- RAINIERIndependent statistical analysis of Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- RAISE-BPIndependent statistical analysis of Using Mirabegron to Increase BP in Patients With POTS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06133075).
- RALDARIndependent statistical analysis of Dual Therapy With Raltegravir and Darunavir/Ritonavir in HIV Infected Patients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01258374).
- RALLYIndependent statistical analysis of A Phase 3 Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With Fibromyalgia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients: Complete Statistical AnalysisIndependent statistical analysis of Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial): Complete Statistical AnalysisIndependent statistical analysis of Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial): primary endpoint results, effect…
- Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme: Complete Statistical AnalysisIndependent statistical analysis of Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 5 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Elderly Patients: Complete Statistical AnalysisIndependent statistical analysis of Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 5 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Elderly Patients: primary endpoint results,…
- Randomised Study Comparing the Effects of Inhaled FF/GW642444M Combination, FF and GW642444M on an Allergen Induced Asthmatic Response: Complete Statistical AnalysisIndependent statistical analysis of Randomised Study Comparing the Effects of Inhaled FF/GW642444M Combination, FF and GW642444M on an Allergen Induced Asthmatic Response: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Randomised, Double- Blind, Cross-over Efficacy and Safety Comparison of Three Different Doses of Tiotropium Administered Once Daily Versus Placebo in Patients With Moderate Persistent Asthma.: Complete Statistical AnalysisIndependent statistical analysis of Randomised, Double- Blind, Cross-over Efficacy and Safety Comparison of Three Different Doses of Tiotropium Administered Once Daily Versus Placebo in Patients With Moderate Persistent Asthma.: primary endpoint results,…
- Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed.: Complete Statistical AnalysisIndependent statistical analysis of Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Randomized Controlled Trial of Group Prevention Coaching: Complete Statistical AnalysisIndependent statistical analysis of Randomized Controlled Trial of Group Prevention Coaching: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01838226).
- Randomized Controlled Trial of Tranexamic Acid in Total Knee Arthroplasty: Intravenous vs. Topical: Complete Statistical AnalysisIndependent statistical analysis of Randomized Controlled Trial of Tranexamic Acid in Total Knee Arthroplasty: Intravenous vs. Topical: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Randomized Controlled Trial of Trauma-focused CBT in Tanzania and Kenya: Complete Statistical AnalysisIndependent statistical analysis of Randomized Controlled Trial of Trauma-focused CBT in Tanzania and Kenya: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01822366).
- Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00552409).
- Randomized Controlled Trial to Test an Alzheimer’s Family Caregiver Intervention in Vietnam: Complete Statistical AnalysisIndependent statistical analysis of Randomized Controlled Trial to Test an Alzheimer's Family Caregiver Intervention in Vietnam: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients: Complete Statistical AnalysisIndependent statistical analysis of Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00866879).
- Randomized Crossover Study of Neurally Adjusted Ventilatory Assist (NAVA) in Preterm Infants: Complete Statistical AnalysisIndependent statistical analysis of Randomized Crossover Study of Neurally Adjusted Ventilatory Assist (NAVA) in Preterm Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC): Complete Statistical AnalysisIndependent statistical analysis of Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With Erlotinib in KRAS Wild Type Advanced Non-Small Cell Lung Cancer (NSCLC) and a Randomized Phase II Study of AZD6244 With Erlotinib in Mutant KRAS Adva…: Complete Statistical AnalysisIndependent statistical analysis of Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With Erlotinib in KRAS Wild Type Advanced Non-Small Cell Lung Cancer (NSCLC) and a Randomized Phase II…
- Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA): Complete Statistical AnalysisIndependent statistical analysis of Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA): primary endpoint results, effect estimate with…
- Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of Resveratrol, a Plant Polyphenol, for COVID-19: Complete Statistical AnalysisIndependent statistical analysis of Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of Resveratrol, a Plant Polyphenol, for COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy: Complete Statistical AnalysisIndependent statistical analysis of Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02203695).